Evaluation of Rapid Emergency Echography for Acute Dyspnoea
READ
1 other identifier
interventional
461
1 country
5
Brief Summary
Elderly people constitute the largest proportion of emergency room patients, representing 12% of all emergency room admissions. The need for diagnostic tests or therapeutic interventions is much greater in this patient population. Cardiovascular diseases and symptoms represent 12% of the causes for emergency room admission, and patients suffering from cardiovascular disease are those whose emergency room visit lasts longest. The diagnostic approach in the emergency room in elderly patients admitted for acute dypsnoea is complex, and early identification of acute left-sided heart failure (ALSHF) is vital as it has an impact on prognosis. The clinical signs are difficult to interpret, and are non-specific, particularly at the acute phase and in elderly or obese patients. Indeed, some authors have reported up to 50% of diagnostic errors in elderly patients. Measure of the blood concentration of a natriuretic peptide allows a quick diagnosis. However, peptides suffer from several limitations, particularly in situations that are often encountered in elderly patients, such as sepsis, renal failure, acute coronary syndrome, pulmonary embolism, chronic respiratory failure, atrial fibrillation and high body mass index. Diagnostic performance deteriorates with increasing age, and there is a significant increase in this grey-zone in patients aged ≥75 years. In critical situations in elderly patients, assessment of natriuretic peptides serve mainly to rule out a diagnosis of left heart failure. Some authors have suggested using lung ultrasound in the initial work-up of acute respiratory failure, since some specific profiles are known to be related to the presence of interstitial oedema, reflecting impaired left heart function (e.g. presence of B lines). These studies were performed in the context of intensive or critical care, but data are sparse regarding the application of this approach in the emergency room. The hypothesis is that the diagnostic accuracy of a targeted and quick echographic approach, namely the READ method (Rapid Echography for Acute Dyspnoea), comprising targeted lung ultrasound combined with isolated measure of transmitral flow, would be superior to that of NT-proBNP assessment for the diagnosis of ALSHF in elderly patients (≥75 years) admitted to the emergency department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2016
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2015
CompletedFirst Posted
Study publicly available on registry
August 24, 2015
CompletedStudy Start
First participant enrolled
February 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 27, 2022
CompletedJanuary 17, 2025
January 1, 2025
6.8 years
August 12, 2015
January 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To demonstrate the superiority of the READ method over assessment of NT-proBNP for the diagnosis of acute left-sided heart failure in patients aged ≥75 years admitted to the emergency department for acute dyspnoea.
The diagnosis of ALSHF will be established post hoc by two experts based on a specialised echocardiography performed within 7 days after inclusion, or before discharge (whichever occurs first) and on the patient's medical file. The presence of ALSHF using the READ method is defined as presence of diffuse B-lines on lung ultrasound, combined with a restrictive pattern on analysis of transmitral profile. A diagnosis of ALSHF will be retained if the NT-proBNP level is greater than the threshold value of 1800 pg/mL, which is the appropriate threshold for patients aged \>75 years.
1 day
Secondary Outcomes (3)
To evaluate the utility of the combination of the READ method and assessment of NT-proBNP for the diagnosis of ALSHF.
1 day
To assess the potential influence of patients characteristics (age, sex, clinical presentation) on the diagnostic performance of each method of diagnosis (READ and NT-proBNP assessment).
1 day
To evaluate agreement between the results of the READ approach interpreted immediately in the emergency setting, vs deferred evaluation (outside the emergency setting) of the same images by a different operator.
1 day
Study Arms (1)
READ echography
OTHERInterventions
* Echocardiography will be performed before any therapy is initiated by a fully trained operator, according to the READ method. The results of this ultrasound will not be communicated to the clinician managing the patient in the emergency room. * A blood sample will be taken during the routine work-up for centralized evaluation of NT-proBNP levels.
Eligibility Criteria
You may qualify if:
- Admission to the Emergency Department Age ≥ 75 years
- AND criteria of acute dyspnoea:
- Breathe rate ≥ 25 cycles/minute
- or PaO2 ≤ 70 mmHg
- or SpO2 ≤ 92% in room air
- or PacO2 ≥ 45 mmHg and pH ≤ 7.35 AND Electrocardiogram in sinus rhythm or in atrial fibrillation at admission
You may not qualify if:
- Shock i.e. : systolic arterial pressure \<90mmHg; or reduction \>40mmHg or \>30% of usual arterial pressure; or Mean Arterial Pressure \<65mmHG.
- Acute respiratory distress ie : Respiratory rate \>30cpm, use of accessory respiratory muscles, SpO2 \<90% when O2 therapy is required, impaired consciousness,
- Presence of acute coronary syndrome on the ECG
- Other obvious etiological diagnosis (pneumothorax, clinical and radiological manifestations of pneumonia)
- Cardiological or respiratory medicine therapies initiated before the READ approach could be put in place (at patient's home, pre-hospital and/or in the emergency department) i.e.. diuretic, vasoactive drugs (nitrovasodilator, sympathomimetic and cardiotonic drugs, vasodilators and vasoconstrictors); or Continuous Positive Airway Pressure (CPAP); or invasive or non-invasive ventilation.
- Patient not affiliated to or beneficiary of the French social security system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire de Besanconlead
- Centre Hospitalier Germon et Gauthiercollaborator
- University Hospital, Clermont-Ferrandcollaborator
- Centre Hospitalier de PAUcollaborator
- University Hospital, Strasbourg, Francecollaborator
- Centre Hospitalier Général de Touloncollaborator
Study Sites (5)
University Hospital of Clermont-Ferrand
Clermont-Ferrand, Auvergne, 63000, France
University Hospital of Strasbourg
Strasbourg, Grand Est, 67000, France
Centre hospitalier de Pau
Pau, Nouvelle-Aquitaine, 64000, France
University Hospital of Toulouse
Toulouse, Occitanie, 31000, France
Centre Hospitalier de Toulon
Toulon, Provence-Alpes-Côte d'Azur Region, 83000, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2015
First Posted
August 24, 2015
Study Start
February 29, 2016
Primary Completion
December 20, 2022
Study Completion
December 27, 2022
Last Updated
January 17, 2025
Record last verified: 2025-01